Goosehead Insurance, Inc

NasdaqGS:GSHD Stock Report

Mkt Cap: US$1.7b

We’ve recently updated our valuation analysis.

Goosehead Insurance Valuation

Is GSHD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for GSHD?

Other financial metrics that can be useful for relative valuation.

GSHD key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue5.8x
Enterprise Value/EBITDA104.6x
PEG Ratio20.9x

Price to Book Ratio vs Peers

How does GSHD's PB Ratio compare to its peers?

The above table shows the PB ratio for GSHD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPBEstimated GrowthMarket Cap
Peer Average3.4x
WDH Waterdrop
1.8x17.0%US$1.2b
HGTY Hagerty
8.3x25.9%US$3.4b
HIPO Hippo Holdings
0.7x42.0%US$434.5m
BRP BRP Group
2.9x-34.9%US$3.6b
GSHD Goosehead Insurance
160.5x142.9%US$1.7b

Price-To-Book vs Peers: GSHD is expensive based on its Price-To-Book Ratio (160.5x) compared to the peer average (3.4x).


Price to Earnings Ratio vs Industry

How does GSHD's PE Ratio compare vs other companies in the US Insurance Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a20.0%
n/an/an/a

Price-To-Book vs Industry: GSHD is expensive based on its Price-To-Book Ratio (160.5x) compared to the US Insurance industry average (1.4x)


Price to Book Ratio vs Fair Ratio

What is GSHD's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

GSHD PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio160.5x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate GSHD's Price-To-Book Fair Ratio for valuation analysis.


Share Price vs Fair Value

What is the Fair Price of GSHD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate GSHD's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate GSHD's fair value for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst GSHD forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$44.79
US$55.25
+23.4%
38.5%US$100.00US$29.00n/a8
Jan ’24US$34.34
US$62.00
+80.5%
37.6%US$100.00US$29.00n/a7
Dec ’23US$40.40
US$62.00
+53.5%
37.6%US$100.00US$29.00n/a7
Nov ’23US$40.58
US$62.00
+52.8%
37.6%US$100.00US$29.00n/a7
Oct ’23US$35.64
US$76.32
+114.1%
38.0%US$120.00US$36.00n/a8
Sep ’23US$49.63
US$76.32
+53.8%
38.0%US$120.00US$36.00n/a8
Aug ’23US$55.94
US$76.32
+36.4%
38.0%US$120.00US$36.00n/a8
Jul ’23US$46.58
US$88.57
+90.1%
35.4%US$122.00US$36.00n/a8
Jun ’23US$48.36
US$89.82
+85.7%
36.4%US$130.00US$36.00n/a8
May ’23US$57.49
US$93.82
+63.2%
29.2%US$130.00US$60.00n/a8
Apr ’23US$79.19
US$126.86
+60.2%
19.3%US$155.00US$75.00n/a7
Mar ’23US$77.96
US$128.29
+64.6%
16.8%US$155.00US$85.00n/a7
Feb ’23US$95.12
US$142.00
+49.3%
17.8%US$181.00US$95.00US$40.927
Jan ’23US$130.08
US$159.00
+22.2%
10.0%US$181.00US$135.00US$34.347
Dec ’22US$127.01
US$159.00
+25.2%
10.0%US$181.00US$135.00US$40.407
Nov ’22US$139.04
US$159.00
+14.4%
10.0%US$181.00US$135.00US$40.587
Oct ’22US$153.47
US$147.57
-3.8%
9.9%US$170.00US$123.00US$35.647
Sep ’22US$149.27
US$141.60
-5.1%
8.7%US$155.00US$123.00US$49.635
Aug ’22US$120.19
US$140.20
+16.6%
6.9%US$155.00US$126.00US$55.945
Jul ’22US$127.62
US$138.20
+8.3%
7.6%US$155.00US$126.00US$46.585
Jun ’22US$88.65
US$127.75
+44.1%
15.3%US$155.00US$100.00US$48.364
May ’22US$109.94
US$139.00
+26.4%
8.4%US$155.00US$126.00US$57.494
Apr ’22US$111.00
US$156.50
+41.0%
13.0%US$177.00US$129.00US$79.194
Mar ’22US$125.48
US$156.50
+24.7%
13.0%US$177.00US$129.00US$77.964
Feb ’22US$133.71
US$137.25
+2.6%
9.1%US$155.00US$125.00US$95.124

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies